Anticorps Monoclonal anti-CD109
CD109 Monoclonal Antibody for FC, WB,ELISA
Hôte / Isotype
Mouse / IgG1
Réactivité testée
Humain
Applications
WB, IHC, FC, ELISA
Conjugaison
Non conjugué
CloneNo.
2H8G7
N° de cat : 60179-1-Ig
Synonymes
Galerie de données de validation
Applications testées
Résultats positifs en WB | cellules Jurkat |
Résultats positifs en cytométrie | cellules Jurkat, |
Dilution recommandée
Application | Dilution |
---|---|
Western Blot (WB) | WB : 1:1000-1:8000 |
Flow Cytometry (FC) | FC : 1:10-1:100 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, check data in validation data gallery |
Applications publiées
WB | See 1 publications below |
IHC | See 1 publications below |
Informations sur le produit
60179-1-Ig cible CD109 dans les applications de WB, IHC, FC, ELISA et montre une réactivité avec des échantillons Humain
Réactivité | Humain |
Réactivité citée | Humain |
Hôte / Isotype | Mouse / IgG1 |
Clonalité | Monoclonal |
Type | Anticorps |
Immunogène | Peptide |
Nom complet | CD109 molecule |
Masse moléculaire calculée | 162 kDa |
Poids moléculaire observé | 162 kDa |
Numéro d’acquisition GenBank | BC152996 |
Symbole du gène | CD109 |
Identification du gène (NCBI) | 135228 |
Conjugaison | Non conjugué |
Forme | Liquide |
Méthode de purification | Précipitation de l'acide caprylique/du sulfate d'ammonium |
Tampon de stockage | PBS avec azoture de sodium à 0,02 % et glycérol à 50 % pH 7,3 |
Conditions de stockage | Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. |
Informations générales
CD109, also named as CPAMD7, is a member of the alpha2-macroglobulin/complement superfamily. It is a glycosylphosphatidylinositol (GPI)-linked cell surface glycoprotein of approximately 170kd which is found on the cell surface of platelets, activated T-cells, and endothelial cells. CD109 binds to and negatively regulates signaling of transforming growth factor beta (TGF-beta). CD109 has been identified as part of the TGF-beta receptor system in human keratinocytes. Up regulation of CD109 expression has been observed in several different types of tumor.CD109 is a glycosyl-phosphatidylinositol-anchored glycoprotein that is a member of the a2-macroglobulin/C3, C4, C5 family of thioester-containing proteins. There're 2 forms of 150 (p150) and 120 kDa (p120) exist due to proteolytic degradation from a 180 kDa form. The antibody can recognize all these 4 isoforms.
Protocole
Product Specific Protocols | |
---|---|
WB protocol for CD109 antibody 60179-1-Ig | Download protocol |
FC protocol for CD109 antibody 60179-1-Ig | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
Publications
Species | Application | Title |
---|---|---|
Clin Oral Implants Res Characterization of macrophages infiltrating peri-implantitis lesions. | ||
Drug Dev Res Curcumin mitigates the epithelial-to-mesenchymal transition in biliary epithelial cells through upregulating CD109 expression. | ||
Mol Carcinog Tandem mass tag (TMT) quantitative protein analysis-based proteomics and parallel reaction monitoring (PRM) validation revealed that MST4 accelerates osteosarcoma proliferation by increasing MRC2 activity |